Vitamin D Deficiency in Chronic Liver Disease: Prevalence, Risk Factors and Clinical Implications
DOI:
https://doi.org/10.70749/ijbr.v3i3.793Keywords:
Vitamin D Deficiency, Chronic Liver Disease, Prevalence, Clinical ImplicationsAbstract
Background: Vitamin D deficiency is a common issue in patients with chronic liver disease (CLD), particularly those with cirrhosis, non-alcoholic fatty liver disease (NAFLD), and chronic viral hepatitis. Objective: This study aims to assess the prevalence of vitamin D deficiency in CLD patients, identify associated risk factors, and explore the clinical implications of the deficiency. Methods: This cross-sectional study was conducted at Social Security Teaching Hospital Lahore during July 2024 to December 2024. A total of 178 patients with chronic liver disease were included in the study. The analysis integrated both medical records with laboratory test results. A comprehensive clinical evaluation included numerous factors, including the nature and length of liver disease, plus patients' lifestyle behavior and their consumption of sunlight and intake of vitamin D supplements. Results: The study examined 178 patients; the results showed that 109 (61%) patients had vitamin D deficiency, whereas 37 (21%) patients had vitamin D insufficiency, while 32 (18%) patients received sufficient vitamin D levels. The presence of vitamin D deficiency reached its peak at 70% in patients with cirrhosis, while those with NAFLD had a prevalence rate of 54%, and chronic viral hepatitis patients had 60% deficiency cases. Conclusion: The risk factors associated with vitamin D deficiency included advanced stages of liver disease based on Child-Pugh score together with high BMI, minimal exposure to sunlight, and inadequate vitamin D consumption. This study demonstrates the need for regular vitamin D deficiency tests among CLD patients because such insufficiency leads to grave medical outcomes that affect bone strength and muscular control and boost disease susceptibility.
Downloads
References
Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci. 2010 Sep;55(9):2624-8. https://doi.org/10.1007/s10620-009-1069-9.
Azevedo LA, Matte U, Silveira TR, Bonfanti JW, Bruch JP, Álvares-da-Silva MR. Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C. Ann Hepatol. 2017 Sep-Oct;16(5):742-748. https://doi.org/10.5604/01.3001.0010.2748.
Rozmus D, Płomiński J, Augustyn K, Cieślińska A. rs7041 and rs4588 Polymorphisms in Vitamin D Binding Protein Gene (VDBP) and the Risk of Diseases. Int J Mol Sci. 2022 Jan 15;23(2):933. https://doi.org/10.3390/ijms23020933.
Cashman K.D., Dowling K.G., Škrabáková Z., Gonzalez-Gross M., Valtueña J., De Henauw S., Moreno L., Damsgaard C.T., Michaelsen K.F., Mølgaard C., et al. Vitamin D deficiency in Europe: Pandemic? Am. J. Clin. Nutr. 2016;103:1033–1044. https://doi.org/10.3945/ajcn.115.120873.
Ames BN, Grant WB, Willett WC. Does the high prevalence of vitamin D deficiency in African Americans contribute to health disparities? Nutrients. 2021;13(2):499. https://doi.org/10.3390/nu13020499.
Liberman UA. Disorders in Vitamin D action. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Hershman JM, Hofland J, Kalra S, et al., editors. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2000.
Van Driel M, van Leeuwen JP. Vitamin D endocrinology of bone mineralization. Mol Cell Endocrinol. 2017;453:46-51. https://doi.org/10.1016/j.mce.2017.06.008.
Mays S, Brickley MB. Vitamin D deficiency in bioarchaeology and beyond: The study of rickets and osteomalacia in the past. Int J Paleopathol. 2018;23:1-5. https://doi.org/10.1016/j.ijpp.2018.05.004.
Ismailova A, White JH. Vitamin D, infections and immunity. Rev Endocr Metab Disord. 2021:1-13. https://doi.org/10.1007/s11154-021-09679-5.
Dimitrov V, Barbier C, Ismailova A, Wang Y, Dmowski K, Salehi-Tabar R, Memari B, Groulx-Boivin E, White JH. Vitamin D-regulated gene expression profiles: species-specificity and cell-specific effects on metabolism and immunity. Endocrinology. 2021;162(4):bqaa218. https://doi.org/10.1210/endocr/bqaa218.
Bikle DD. Vitamin D: An ancient hormone. Exp Dermatol. 2010;20(1):7-13. https://doi.org/10.1111/j.1600-0625.2010.01202.x.
Balachandar R, Pullakhandam R, Kulkarni B, Sachdev HS. Relative efficacy of vitamin D2 and vitamin D3 in improving vitamin D status: systematic review and meta-analysis. Nutrients. 2021;13(10):3328. https://doi.org/10.3390/nu13103328.
Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85(8):752-758. https://doi.org/10.4065/mcp.2010.0138.
Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319-329. https://doi.org/10.1016/j.chembiol.2013.12.016.
Holick MF, MacLaughlin JA, Doppelt SH. Regulation of cutaneous previtamin D3 photosynthesis in man: Skin pigment is not an essential regulator. Science. 1981;211(4482):590-593. https://doi.org/10.1126/science.6256855.
Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 2004;29(11):664-673. https://doi.org/10.1016/j.tibs.2004.10.005.
Slominski AT, Kim T, Shehabi HZ, Semak I, Tang EKY, Nguyen MN, Benson HAE, Korik E, Janjetovic Z, Chen J, et al. In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 2012;26(9):3901-3915. https://doi.org/10.1096/fj.12-208975.
Slominski AT, Kim T-K, Li W, Postlethwaite A, Tieu EW, Tang EKY, Tuckey RC. Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. Sci Rep. 2015;5:14875. https://doi.org/10.1038/srep14875.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
